Sensus Healthcare, Inc. (SRTS)
NASDAQ: SRTS · Real-Time Price · USD
3.080
-0.040 (-1.28%)
Sep 18, 2026, 9:44 AM EDT - Market open
Sensus Healthcare Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 51 | 65 | 113 | 39 | 123 | 120 | |
Market Cap Growth | -2.12% | -42.36% | 193.36% | -68.63% | 2.74% | 88.35% |
Enterprise Value | 36 | 41 | 92 | 19 | 87 | 104 |
Last Close Price | 3.12 | 3.98 | 6.92 | 2.36 | 7.42 | 7.22 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 17.06 | 79.72 | 5.08 | 29.13 |
Forward PE | - | 17.90 | 13.66 | 16.99 | 9.01 | 41.86 |
PS Ratio | 2.87 | 2.38 | 2.71 | 1.58 | 2.77 | 4.44 |
PB Ratio | 1.39 | 1.36 | 2.03 | 0.79 | 2.56 | 4.61 |
P/TBV Ratio | 1.36 | 1.36 | 2.03 | 0.79 | 2.56 | 4.64 |
P/FCF Ratio | - | 196.90 | - | - | - | - |
P/OCF Ratio | - | 123.81 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.02 | 1.51 | 2.19 | 0.78 | 1.95 | 3.84 |
EV/EBITDA Ratio | - | - | 10.99 | - | 5.73 | 21.96 |
EV/EBIT Ratio | - | - | 11.31 | - | 5.85 | 25.23 |
EV/FCF Ratio | - | 124.86 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 |
Debt / EBITDA Ratio | - | - | 0.07 | 8.42 | 0.07 | 0.04 |
Debt / FCF Ratio | - | 1.42 | - | - | - | - |
Net Debt / Equity Ratio | -0.40 | -0.45 | -0.38 | -0.46 | -0.51 | -0.55 |
Net Debt / EBITDA Ratio | 1.15 | 2.18 | -2.58 | 209.02 | -1.62 | -3.02 |
Net Debt / FCF Ratio | 2.13 | -65.10 | 19.38 | 9.42 | 15.60 | 34.53 |
Asset Turnover | 0.35 | 0.48 | 0.72 | 0.44 | 1.00 | 0.90 |
Inventory Turnover | 0.65 | 1.06 | 1.23 | 0.84 | 2.12 | 2.31 |
Quick Ratio | 3.90 | 5.96 | 7.10 | 8.02 | 5.56 | 4.47 |
Current Ratio | 8.71 | 9.72 | 9.64 | 11.76 | 6.92 | 5.24 |
Return on Equity (ROE) | -34.83% | -14.85% | 12.70% | 1.00% | 65.45% | 17.34% |
Return on Assets (ROA) | -16.55% | -11.18% | 8.73% | -0.43% | 20.84% | 8.55% |
Return on Invested Capital (ROIC) | -53.40% | -33.87% | 19.59% | -1.14% | 72.80% | 41.84% |
Return on Capital Employed (ROCE) | -35.90% | -21.30% | 14.40% | -0.80% | 30.20% | 15.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -30.84% | -11.81% | 5.86% | 1.25% | 19.67% | 3.43% |
FCF Yield | -13.88% | 0.51% | -0.98% | -6.14% | -1.27% | -0.34% |
Buyback Yield / Dilution | -0.39% | 0.20% | -0.57% | 2.12% | -0.70% | -0.42% |